diffquik fixative solution (Sysmex Corporation)
90
Structured Review
Sysmex Corporation
diffquik fixative solution
Diffquik Fixative Solution, supplied by Sysmex Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/diffquik+solution/diffquik+fixative+solution/pm33242180-81-19-30
Average 90 stars, based on 1 article reviews
Diffquik Fixative Solution, supplied by Sysmex Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/diffquik+solution/diffquik+fixative+solution/pm33242180-81-19-30
Average 90 stars, based on 1 article reviews
diffquik fixative solution - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Incubation:Article Title: NRF2 level is negatively correlated with TGF-β1-induced lung cancer motility and migration via NOX4-ROS signaling. Article Snippet: Epithelial-to-mesenchymal transition (EMT) is characterized by a loss of epithelial markers such as E-cadherin and the acquisition of epithelium-derived cancer cells of mesenchymal properties (Greenburg and Hay 1982).. Cellular changes by EMT include the attenuation of epithelial polarity, rearrangement of cell–cell adhesion contacts, and increase in cancer metastasis and invasiveness (Greenburg and Hay 1982; Saitoh 2018).. Transforming growth factor-β1 (TGF-β1) is well-known to regulate various responses in human cancer cells, including cell proliferation, metastasis, and EMT (Oft et al. 1998; Liu et al. 2018). Membrane:Article Title: NRF2 level is negatively correlated with TGF-β1-induced lung cancer motility and migration via NOX4-ROS signaling. Article Snippet: Epithelial-to-mesenchymal transition (EMT) is characterized by a loss of epithelial markers such as E-cadherin and the acquisition of epithelium-derived cancer cells of mesenchymal properties (Greenburg and Hay 1982).. Cellular changes by EMT include the attenuation of epithelial polarity, rearrangement of cell–cell adhesion contacts, and increase in cancer metastasis and invasiveness (Greenburg and Hay 1982; Saitoh 2018).. Transforming growth factor-β1 (TGF-β1) is well-known to regulate various responses in human cancer cells, including cell proliferation, metastasis, and EMT (Oft et al. 1998; Liu et al. 2018). Staining:Article Title: NRF2 level is negatively correlated with TGF-β1-induced lung cancer motility and migration via NOX4-ROS signaling. Article Snippet: Epithelial-to-mesenchymal transition (EMT) is characterized by a loss of epithelial markers such as E-cadherin and the acquisition of epithelium-derived cancer cells of mesenchymal properties (Greenburg and Hay 1982).. Cellular changes by EMT include the attenuation of epithelial polarity, rearrangement of cell–cell adhesion contacts, and increase in cancer metastasis and invasiveness (Greenburg and Hay 1982; Saitoh 2018).. Transforming growth factor-β1 (TGF-β1) is well-known to regulate various responses in human cancer cells, including cell proliferation, metastasis, and EMT (Oft et al. 1998; Liu et al. 2018). Diff-Quik:Article Title: NRF2 level is negatively correlated with TGF-β1-induced lung cancer motility and migration via NOX4-ROS signaling. Article Snippet: Epithelial-to-mesenchymal transition (EMT) is characterized by a loss of epithelial markers such as E-cadherin and the acquisition of epithelium-derived cancer cells of mesenchymal properties (Greenburg and Hay 1982).. Cellular changes by EMT include the attenuation of epithelial polarity, rearrangement of cell–cell adhesion contacts, and increase in cancer metastasis and invasiveness (Greenburg and Hay 1982; Saitoh 2018).. Transforming growth factor-β1 (TGF-β1) is well-known to regulate various responses in human cancer cells, including cell proliferation, metastasis, and EMT (Oft et al. 1998; Liu et al. 2018). |